Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chetan Mukhtyar

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
The Journal of the Royal College of Physicians of Edinburgh|June 23, 2020
Hydroxychloroquine and coronavirus disease 2019Chetan Mukhtyar
Rheumatology (Oxford, England)|November 26, 2019
The need to establish standards of care for Giant Cell ArteritisChetan Mukhtyar, Humphrey Hodgson
Polskie Archiwum Medycyny Wewnetrznej|November 23, 2016
How to treat ANCA‑associated vasculitis: practical messages from 2016 EULAR/ERA‑EDTA recommendationsJan Sznajd, Chetan Mukhtyar
Rheumatology Advances in Practice|April 5, 2021
Comment on: Evaluation of adjunctive mycophenolate for large vessel giant cell arteritisRifat Mazumder, Chetan Mukhtyar
International Journal of Rheumatic Diseases|April 4, 2018
Are PR3 positive and MPO positive GPA the same disease?Sarah Fordham, Chetan Mukhtyar
Rheumatology (Oxford, England)|May 6, 2021
The long-term use of tocilizumab in giant cell arteritisFiona Louise Coath, Chetan Mukhtyar
Rheumatology (Oxford, England)|February 18, 2021
Ultrasonography in the diagnosis and follow-up of giant cell arteritisFiona L Coath, Chetan Mukhtyar
Rheumatology (Oxford, England)|April 20, 2018
Why subcutaneous methotrexate should be a prerequisite to biologic use in patients with rheumatoid arthritisGouri M Koduri, Chetan Mukhtyar
Best Practice & Research. Clinical Rheumatology|June 11, 2009
Cardiovascular involvement in primary systemic vasculitisChetan Mukhtyar, Paul Brogan, Raashid Luqmani
Expert Review of Clinical Immunology|May 19, 2010
Update on the use of biologics in primary systemic vasculitidesChetan Mukhtyar, Antoni Chan, Raashid Luqmani
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
The Journal of the Royal College of Physicians of Edinburgh|June 23, 2020
Hydroxychloroquine and coronavirus disease 2019Chetan Mukhtyar
Rheumatology (Oxford, England)|November 26, 2019
The need to establish standards of care for Giant Cell ArteritisChetan Mukhtyar, Humphrey Hodgson
Polskie Archiwum Medycyny Wewnetrznej|November 23, 2016
How to treat ANCA‑associated vasculitis: practical messages from 2016 EULAR/ERA‑EDTA recommendationsJan Sznajd, Chetan Mukhtyar
Rheumatology Advances in Practice|April 5, 2021
Comment on: Evaluation of adjunctive mycophenolate for large vessel giant cell arteritisRifat Mazumder, Chetan Mukhtyar
International Journal of Rheumatic Diseases|April 4, 2018
Are PR3 positive and MPO positive GPA the same disease?Sarah Fordham, Chetan Mukhtyar
Rheumatology (Oxford, England)|May 6, 2021
The long-term use of tocilizumab in giant cell arteritisFiona Louise Coath, Chetan Mukhtyar
Rheumatology (Oxford, England)|February 18, 2021
Ultrasonography in the diagnosis and follow-up of giant cell arteritisFiona L Coath, Chetan Mukhtyar
Rheumatology (Oxford, England)|April 20, 2018
Why subcutaneous methotrexate should be a prerequisite to biologic use in patients with rheumatoid arthritisGouri M Koduri, Chetan Mukhtyar
Best Practice & Research. Clinical Rheumatology|June 11, 2009
Cardiovascular involvement in primary systemic vasculitisChetan Mukhtyar, Paul Brogan, Raashid Luqmani
Expert Review of Clinical Immunology|May 19, 2010
Update on the use of biologics in primary systemic vasculitidesChetan Mukhtyar, Antoni Chan, Raashid Luqmani
Pageof 6